Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -521,960 | -417,371 | -203,654 | -65,276 | -615,117 |
| Depreciation Amortization | 19,956 | 14,902 | 11,652 | 4,755 | 10,745 |
| Income taxes - deferred | N/A | N/A | -363 | N/A | N/A |
| Accounts payable and accrued liabilities | -988 | 948 | -2,158 | 735 | 732 |
| Other Working Capital | -83,322 | -66,321 | -83,814 | -82,147 | -332,709 |
| Other Operating Activity | 139,962 | 109,125 | 91,100 | 32,543 | 157,564 |
| Operating Cash Flow | $-446,352 | $-358,717 | $-187,237 | $-109,390 | $-778,785 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 503,296 | 363,019 | 241,653 | 29,759 | 186,202 |
| PPE Investments | -3,929 | -4,389 | -1,626 | -1,339 | -21,573 |
| Investing Cash Flow | $499,367 | $358,630 | $240,027 | $28,420 | $164,629 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -69 | N/A |
| Common Stock Issued | 4,553 | 3,303 | 3,232 | 221 | 7,767 |
| Other Financing Activity | -165 | -178 | -138 | 0 | -287 |
| Financing Cash Flow | $4,388 | $3,125 | $3,094 | $152 | $7,480 |
| Beginning Cash Position | 261,292 | 261,292 | 261,292 | 261,292 | 867,968 |
| End Cash Position | 318,695 | 264,330 | 317,176 | 180,474 | 261,292 |
| Net Cash Flow | $57,403 | $3,038 | $55,884 | $-80,818 | $-606,676 |
| Free Cash Flow | |||||
| Operating Cash Flow | -446,352 | -358,717 | -187,237 | -109,390 | -778,785 |
| Capital Expenditure | -7,301 | -5,306 | -2,538 | -1,872 | -21,573 |
| Free Cash Flow | -453,653 | -364,023 | -189,775 | -111,262 | -800,358 |